Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Board Blames Woes on Middle Managers, Staff Cuts
Motley Fool
Saturday, July 23, 2011 - 4:32pm
tags:
JNJ
J&J Wins European Panel’s Backing of Cancer, Hepatitis Drugs
Bloomberg
Saturday, July 23, 2011 - 4:32pm
tags:
JNJ, Incivo, hepatitis C, Zytiga, prostate cancer
Could Eli Lilly's Stock Double Your Money?
Motley Fool
Saturday, July 23, 2011 - 4:28pm
tags:
Eli Lilly
The Next Big Thing In Biotech: Celgene
The Street
Saturday, July 23, 2011 - 4:27pm
tags:
Celgene
Regeneron Pharmaceuticals Earnings Preview
Motley Fool
Saturday, July 23, 2011 - 4:27pm
tags:
Regeneron, earnings
InterMune, Inc. Second Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Saturday, July 23, 2011 - 3:22pm
tags:
InterMune, earnings
Analyst calls Human Genome sell-off "overdone"
MarketWatch
Saturday, July 23, 2011 - 3:21pm
tags:
Human Genome
That's All the Melanoma Market Is Worth?
Motley Fool
Saturday, July 23, 2011 - 3:21pm
tags:
melanoma, BioSante, melanoma vaccine, vaccines, cancer vaccines
Ligand Pharmaceuticals
Yahoo/The Street
Saturday, July 23, 2011 - 3:18pm
tags:
Ligand
PDL BioPharma: Dividend Dynamo or Blowup?
Motley Fool
Saturday, July 23, 2011 - 3:17pm
tags:
PDL Biopharma
These 2 Biotechs Are Dangerous Investments
Motley Fool
Saturday, July 23, 2011 - 3:16pm
tags:
Pharmasset, Ariad Pharmaceuticals
3 Oversold, Highly Shorted Stocks Being Snapped up by Insiders
Seeking Alpha
Saturday, July 23, 2011 - 3:15pm
tags:
MannKind, Seattle Genetics
Bristol-Myers Acquires Amira Pharmaceuticals, Scoops Up Lung Drug
Motley Fool
Saturday, July 23, 2011 - 3:13pm
tags:
Amira, Bristol-Myers Squibb, pulmonary fibrosis
9 Small Biotechs Near 52-Week Lows
Motley Fool
Saturday, July 23, 2011 - 3:11pm
tags:
MannKind, Alnylam, Theratechnologies, Metabolix, Cell Therapeutics, Novavax, AVI BioPharma, Allos, Vanda
Don't Miss Out On the Upcoming Boom in Biosimilars
Yahoo/SmallCapInvestor
Saturday, July 23, 2011 - 3:09pm
tags:
biosimilars, Dr Reddy's, Spectrum Pharmaceuticals
Amarin Must Be Acquired - And There Are Plenty of Potential Suitors
Seeking Alpha
Friday, July 22, 2011 - 6:36pm
tags:
Amarin, M&A, GSK, Pfizer
AMAG-Allos, a Match Made in Necessity
Motley Fool
Friday, July 22, 2011 - 11:18am
tags:
Allos, Amag Pharmaceuticals, M&A
BioSante: A Serendipitous Moment?
Seeking Alpha
Friday, July 22, 2011 - 11:17am
tags:
BioSante
Does Pharma Have a Debt Crisis Strategy?
PharmExec
Friday, July 22, 2011 - 10:46am
tags:
debt
J&J warns doctors of Doxil cancer-drug shortage
Reuters
Friday, July 22, 2011 - 10:37am
tags:
JNJ, physicians, Doxil, drug shortages

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.